ATLANTA (GenomeWeb) – Cepheid has announced that it will enter the point-of-care molecular diagnostics market next year with a new platform called the GeneXpert Omni.

The device will use the firm's menu of GeneXpert cartridges, and will be smaller, lighter, and less expensive than other currently commercially available platforms for point-of-care nucleic acid detection.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.